Fig. 7
From: Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer
CD226, KLRD1 and KLRC4-KLRK1 had higher predictive accuracies than the other screened genes. Time-dependent ROC analyses were performed to compare the 15 screened gene signatures: (A) CD226, (B) KLRD1, (C) KLRC4-KLRK1, (D) IL2, (E) KLRK1, (F) ITK, (G) SPN, (H) SLAMF1, (I) CD1C, (J) FASLG, (K) CD40LG, (L) TBX21, (M) IL7, (N) LAT, and (O) ITGAX in predicting 1-year, 3-year and 5-year overall survival